CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Common Stock	Common Stock Warrants	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017		4,960,552
Beginning balance at Dec. 31, 2017	$ 4,434,987	$ 49,606			$ 17,402,911	$ 0	$ (13,017,530)
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustment	451					451
Stock-based compensation expense	1,074,687				1,074,687
Net loss	(18,219,664)						(18,219,664)
Ending balance at Dec. 31, 2018	(12,709,539)	$ 49,606			18,477,598	451	(31,237,194)
Ending balance (in shares) at Dec. 31, 2018		4,960,552
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustment	(451)					$ (451)
Stock-based compensation expense	884,089				884,089
Net loss	(20,242,630)						(20,242,630)
Issuance of common stock (in shares)		80,569	40,542,222
Issuance of common stock for Subscription Agreement	1,000,000	$ 806			999,194
Conversion of debt (in shares)		1,125,673
Conversion of debt	13,979,788	$ 11,256			13,968,532
Issuance of common stock and warrants for pre-Merger Financing (in shares)		4,385,964
Issuance of common stock and warrants for Pre-Merger Financing	13,150,456	$ 43,860			13,106,596
Issuance of stock for reverse asset acquisition, net of $2.6 million of costs (in shares)		1,651,748
Issuance of stock for reverse asset acquisition, net of $2.6 million of costs	3,565,788	$ 16,517			3,549,271
Reclassification of Series B Warrants from liability to equity	11,255,740				11,255,740
Issuance of common stock for warrant exercises, net	183,034	405,422			(222,388)
Repurchase of treasury stock	(47,864)			$ (47,864)
Ending balance at Dec. 31, 2019	$ 11,018,411	$ 527,467		$ (47,864)	$ 62,018,632		$ (51,479,824)
Ending balance (in shares) at Dec. 31, 2019		52,746,728